C2C on Lancet Haematology


A viewpoint article with many contribution from international authorities in the management of sickle cell disease, including advances in supportive care, bone marrow transplantation and gene therapy. C2C contributed to the paragraph on "The challenge of curative approaches in low-income and middle-income countries".